Literature DB >> 11068982

Expression of osteopontin in calcified coronary atherosclerotic plaques.

H M Kwon1, B K Hong, T S Kang, K Kwon, H K Kim, Y Jang, D Choi, H Y Park, S M Kang, S Y Cho, H S Kim.   

Abstract

Advanced atherosclerosis is often associated with dystrophic calcification and remodeling of extracellular matrix of vascular wall. Recently many studies have documented a general relationship between calcification and severity of coronary disease, and discussed the feasibility of electron beam computed tomography for detecting and quantifying the coronary artery calcification in the patients. The present study investigated the expression and the localization of osteopontin, one of noncollagenous bone matrix protein, within the calcified coronary arteries. Autopsy-derived coronary artery specimens were scanned and reconstructed to visualize the pattern of coronary calcification using a novel microscopic computed tomography technique. The localization of the osteopontin were evaluated by immunohistochemial stain with LF7. The present study showed that the pattern of coronary calcification is variable and the expression of osteopontin is localized mainly to calcified lesion. The smooth muscle cells in addition to macrophage expressed osteopontin protein in human coronary atherosclerotic plaques. Soluble osteopontin released near to the sites of vascular calcification may represent an adaptive mechanism aimed at regulating the process of vascular calcification.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11068982      PMCID: PMC3054686          DOI: 10.3346/jkms.2000.15.5.485

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  11 in total

1.  Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis.

Authors:  Hala Abdel-Hameed Abdel-Azeez; Manar Al-Zaky
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 2.  Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction.

Authors:  Timmy Lee; Davinder Wadehra
Journal:  Semin Dial       Date:  2011-09-15       Impact factor: 3.455

3.  Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trial.

Authors:  Sharon Cresci; Jun Wu; Michael A Province; John A Spertus; Michael Steffes; Janet B McGill; Edwin L Alderman; Maria Mori Brooks; Sheryl F Kelsey; Robert L Frye; Richard G Bach
Journal:  Circulation       Date:  2011-09-12       Impact factor: 29.690

4.  miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice.

Authors:  Wen Ding; Jihe Li; Jayanti Singh; Razan Alif; Roberto I Vazquez-Padron; Samirah A Gomes; Joshua M Hare; Lina A Shehadeh
Journal:  Cardiovasc Res       Date:  2015-02-12       Impact factor: 10.787

5.  Association of plasma osteopontin levels with coronary calcification evaluated by tomographic coronary calcium scoring.

Authors:  Muhammedullah Aryan; Alper Kepez; Enver Atalar; Tuncay Hazirolan; Ibrahim Haznedaroglu; Deniz Akata; Necla Ozer; Serdar Aksoyek; Kanan Ovunc; Ferhan Ozmen
Journal:  J Bone Miner Metab       Date:  2009-04-14       Impact factor: 2.626

6.  Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?

Authors:  Cristina Strobescu-Ciobanu; Simona Eliza Giuşcă; Irina Draga Căruntu; Cornelia Amălinei; Andreea Rusu; Elena Cojocaru; Radu Florin Popa; Cristian Dumitru Lupaşcu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

7.  Expression of osteopontin in patients with thyroid dysfunction.

Authors:  Sara Reza; Asma Shaukat; Tariq M Arain; Qasim Sarwar Riaz; Maria Mahmud
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

8.  Protein targets of inflammatory serine proteases and cardiovascular disease.

Authors:  Ram Sharony; Pey-Jen Yu; Joy Park; Aubrey C Galloway; Paolo Mignatti; Giuseppe Pintucci
Journal:  J Inflamm (Lond)       Date:  2010-08-30       Impact factor: 4.981

9.  Hairy/enhancer of Split Homologue-1 Suppresses Vascular Endothelial Growth Factor-induced Angiogenesis via Downregulation of Osteopontin Expression.

Authors:  Xing-Xing Yao; Jing-Bo Lu; Zhi-Dong Ye; Lei Zheng; Qian Wang; Zhi-Qi Lin; Hao Liu; Heng Wan; Fang-Yong Fu; Xian-Ying Huang; Jian-Chen Xiu; Zheng-Jun Liu; Yan-Wei Hu
Journal:  Sci Rep       Date:  2017-04-18       Impact factor: 4.379

10.  Cut-off value of serum homocysteine in relation to increase of coronary artery calcification.

Authors:  Nam-Seok Joo; Susie Jung; Yu-Na Kim; Beom-Hee Choi
Journal:  J Investig Med       Date:  2020-11-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.